Page 1,208«..1020..1,2071,2081,2091,210..1,2201,230..»

The Next ‘Big Thing’ for Blood Cancers Featured at ASH 2019 – Medscape

Posted: Published on November 30th, 2019

The prospect of an "off-the-shelf" product, rather than one that needs to be grown individually for each patient, is a "very exciting" proposition, say experts discussing new data that will be presented at the forthcoming American Society of Hematology (ASH) meeting. For the last few years, much attention has been focused on chimeric antigen receptor (CAR) T cell products for the treatment of leukemias and lymphomas. These products have been taking center stage at the meeting, mainly "because of their incredible efficacy," commented ASH Secretary Robert A. Continue reading

Posted in Myocardial Infarction | Comments Off on The Next ‘Big Thing’ for Blood Cancers Featured at ASH 2019 – Medscape

Concussions, broken bones, and more: a week of US football – STAT

Posted: Published on November 30th, 2019

News about concussions and other injuries to young football players appears with alarming frequency, as do reports of the long-term damage to NFL players. Young pro players are leaving the game for fear of permanent harm to their brains and bodies. Last month, Joshua Perry discussed his retirement at age 24 after suffering six concussions Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Concussions, broken bones, and more: a week of US football – STAT

Welcome to FIFA.com News – Newcastle rallies around Ash ‘The Flash’ – FIFA.com

Posted: Published on November 30th, 2019

To be sat next to Craig Johnston, Newcastle football royalty, hearing his perspective on the game, and having a beer with him like he was anyone at the pub, it was one of the best nights of my life. Beneath the surface of this unshakable, always-look-on-the-bright-side-of-life Aussie, he must wish watching Central Coast Mariners-Newcastle Jets, in an executive box with the Liverpool icon, had been under vastly difference circumstances. Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Welcome to FIFA.com News – Newcastle rallies around Ash ‘The Flash’ – FIFA.com

JOGO Health to Launch 30 Digital Therapeutics Clinics in Malaysia to Treat Stroke, Pain and Incontinence – BossyNews

Posted: Published on November 30th, 2019

JOGOHEALTH Inc. is a USA based digital therapeutics company which focuses on the commercialization as well as the development of the treatments for the neuromuscular situations like injury in the spinal cord, stroke, cerebral palsy, incontinence, pain and around 17 other conditions. JOGOHEALTH, today has announced that they have entered into the partnership with the JJOGOHealth Stroke Center Sdn. Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on JOGO Health to Launch 30 Digital Therapeutics Clinics in Malaysia to Treat Stroke, Pain and Incontinence – BossyNews

Head to Head Analysis: Invivo Therapeutics (NASDAQ:NVIV) and Vapotherm (NASDAQ:VAPO) – Slater Sentinel

Posted: Published on November 30th, 2019

Invivo Therapeutics (NASDAQ:NVIV) and Vapotherm (NYSE:VAPO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations and institutional ownership. Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Head to Head Analysis: Invivo Therapeutics (NASDAQ:NVIV) and Vapotherm (NASDAQ:VAPO) – Slater Sentinel

How birds fly: New USC study examines the evolution of flight feathers – USC News

Posted: Published on November 29th, 2019

Birds of a feather may flock together, but the feathers of birds differ altogether. New research from an international team led by USC scientists set out to learn how feathers developed and helped birds spread across the world. Continue reading

Posted in Stem Cell Research | Comments Off on How birds fly: New USC study examines the evolution of flight feathers – USC News

Human Embryonic Stem Cells (HESC) Market to Witness an Outstanding Growth by 2020-2029. – Daily Criticism

Posted: Published on November 29th, 2019

Global Human Embryonic Stem Cells (HESC) Marketresearch study recently published by Market.us provided an in-depth analysis of the competitive landscape to give you a complete picture of current and future competitive scenarios of the human embryonic stem cells (hesc) market. The global human embryonic stem cells (hesc) market is predicted to reach at a significant CAGR over the forecast period (2020-2029). It covers all the major developments which are recently being taken up across the global market. Continue reading

Posted in Stem Cell Research | Comments Off on Human Embryonic Stem Cells (HESC) Market to Witness an Outstanding Growth by 2020-2029. – Daily Criticism

Systematic analysis and evaluation of Mesenchymal Stem Cells Market with share, growth rate, Forecasts to 2026 – WindStreetz

Posted: Published on November 29th, 2019

This Mesenchymal Stem Cells research study consists of the historical data from and forecasts till 2026. The report is created keeping in mind to make it a valuable source of information for market specialists in readily accessible documents. The documents are curated with clearly presented graphs and figures. Continue reading

Posted in Stem Cell Research | Comments Off on Systematic analysis and evaluation of Mesenchymal Stem Cells Market with share, growth rate, Forecasts to 2026 – WindStreetz

Lonza and DiNAQOR announce strategic collaboration to advance gene therapy programs for patients with monogenic cardiomyopathies – Pharmaceutical…

Posted: Published on November 29th, 2019

Lonza and DiNAQOR AG, a global gene therapy platform company, announced a strategic collaboration to advance DiNAQOR's preclinical programs for the treatment of cardiac myosin-binding protein-C (MYBPC3) cardiomyopathies, a genetic condition that can result in heart failure. Lonza and DiNAQOR announce strategic collaboration to advance gene therapy programs for patients with monogenic cardiomyopathies. Continue reading

Posted in Cardiomyopathies | Comments Off on Lonza and DiNAQOR announce strategic collaboration to advance gene therapy programs for patients with monogenic cardiomyopathies – Pharmaceutical…

Lonza and DiNAQOR AG Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies – PRNewswire

Posted: Published on November 29th, 2019

BASEL,Switzerland and PFFFIKON,Switzerland, Nov. Continue reading

Posted in Cardiomyopathies | Comments Off on Lonza and DiNAQOR AG Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies – PRNewswire

Page 1,208«..1020..1,2071,2081,2091,210..1,2201,230..»